胺碘酮联合美托洛尔治疗冠心病合并心律失常的效果评估

Effect of Amiodarone Combined with Metoprolol in the Treatment of Coronary Heart Disease Complicated with Arrhythmia

目的:探讨研究胺碘酮联合美托洛尔治疗冠心病合并心律失常的效果。方法:将于某院收治的冠心病合并心律失常患者抽出100例,将其分成观察组与对照组,对照组选择胺碘酮为治疗药物,观察组在此基础上加以美托洛尔治疗,比较两组患者的临床效果。结果:观察组治疗总有效率较对照组高(94.45%>82.22%);观察组不良反应发生率较对照组低(9.99%<21.11%);观察组心率及QTd变化改善情况较对照组对应值优,且P<0.05。结论:采用胺碘酮联合美托洛尔治疗冠心病合并心律失常患者,有效提高其治疗效率的同时有利于减少患者不良反应发生情况,且其心率控制效果显著,值得推广。

Objective:To investigate the effect of amiodarone combined with metoprolol in the treatment of coronary heart disease complicated with arrhythmia.Methods:A total of 100 patients with coronary heart disease complicated with arrhythmia treated in a hospital were selected and divided into observation group and control group.In the control group,amiodarone was selected as the therapeutic drug,and the observation group was treated with metoprolol on the basis of this,and the clinical effects of the two groups of patients were compared.Results:The total effective rate in the observation group was higher than that in the control group(94.45%>82.22%);The incidence of adverse reactions in the observation group was lower than that in the control group(9.99%<21.11%);The improvement of the heart rate and QTd in the observation group was better than that in the control group,and P<0.05.Conclusion:The use of amiodarone combined with metoprolol in the treatment of patients with coronary heart disease complicated with arrhythmia can effectively improve the treatment efficiency and reduce the incidence of adverse reactions at the same time,and its effect on heart rate control is significant and worthy of promotion.